Corinne H Nevinny's Net Worth

$15.8 Million

Estimate Recalculated Jul 2, 2024 08:37PM EST

Who is Corinne H Nevinny?

Corinne H Nevinny has an estimated net worth of $15.8 Million. This is based on reported shares across multiple companies, which include INSULET CORP, NEUROCRINE BIOSCIENCES INC, Edwards Lifesciences Corp, AVANIR PHARMACEUTICALS, INC., ONYX PHARMACEUTICALS INC, and SANGSTAT MEDICAL CORP.

SEC CIK

Corinne H Nevinny's CIK is 0001182467

Past Insider Trading and Trends

2008 was Corinne H Nevinny's most active year for acquiring shares with 9 total transactions. Corinne H Nevinny's most active month to acquire stocks was the month of April. 2008 was Corinne H Nevinny's most active year for disposing of shares, totalling 20 transactions. Corinne H Nevinny's most active month to dispose stocks was the month of September. 2004 saw Corinne H Nevinny paying a total of $1,130,800.00 for 20,162 shares, this is the most they've acquired in one year. In 2010 Corinne H Nevinny cashed out on 26,000 shares for a total of $1,457,160.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

INSULET CORP (PODD) Snapshot price: $199.3

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+16.32%
843
—
—
6.01K
May 23
Form 4
+24.27%
1.01K
—
—
5.17K
May 24
Form 4
+24.12%
808
—
—
4.16K
May 27
Form 4
-21.78%
-933.00
$231.42
-$215,914.86
3.35K
May 13
Form 4
+31.62%
1.03K
—
—
4.28K
May 28
Form 4
-33.77%
-1.66K
$196.21
-$325,505.50
3.25K
Scheduled
Apr 30 - May 1
Form 4
+54.16%
1.73K
—
—
4.91K
May 30
Form 4
∞
3.19K
—
—
3.19K
Jan 25
Form 3
—
0
—
—
0
No matching records found

NEUROCRINE BIOSCIENCES INC (NBIX) Snapshot price: $136.105

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 24
Form 4
-10.36%
-5.00K
$83.13
-$415,625.00
43.28K
Scheduled
May 7
Form 4
+39.53%
13.68K
$43.57
$44.40
48.28K
May 2
Form 4
—
0
—
—
0
May 22
Form 4
-12.63%
-5.00K
$53.98
-$269,900.00
34.6K
Scheduled
May 5
Form 4
+54.97%
14.05K
$28.39
$191.76
39.6K
May 3
Form 4
-16.36%
-5.00K
$48.54
-$242,700.00
25.55K
Scheduled
Aug 8
Form 4/A
—
0
—
—
0
May 28
Form 4
—
0
—
—
0
May 20
Form 4
+84.32%
13.98K
$24.06
$8.90
30.55K
May 3
Form 4
—
0
—
—
0
May 28
Form 4
+406.48%
13.3K
$23.43
$15.36
16.58K
Apr 8
Form 4
—
0
—
—
0
May 22
Form 4
+113.78%
1.74K
$13.42
$6.74
3.27K
May 12
Form 4
—
0
—
—
0
May 23
Form 4
∞
1.53K
$11.38
$1.65
1.53K
Mar 28
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
Aug 28
Form 4
—
0
—
—
0
May 29
Form 4
—
0
—
—
0
May 28
Form 4
—
0
—
—
0
Oct 24
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
Jun 7
Form 3
—
0
—
—
0
No matching records found

Edwards Lifesciences Corp (EW) Snapshot price: $86.94

CVP & Pres., Global Ops

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 13
Form 4
-26.45%
-6.00K
$100.46
-$602,760.00
16.69K
May 10 - May 11
Form 4
—
0
$57.94
-$550,100.00
22.56K
Feb 11
Form 4
—
0
$55.24
-$496,200.00
22.56K
Nov 9
Form 4
-1.10%
-250.00
$53.68
-$465,000.00
22.56K
Oct 27 - Oct 29
Form 4
-20.97%
-6.00K
$62.97
-$377,820.00
22.62K
May 11 - May 12
Form 4
+7.11%
1.9K
—
—
28.62K
May 7
Form 4
-1.48%
-400.00
$38.68
-$188,743.50
26.58K
Nov 21
Form 4
—
0
$41.22
-$184,660.77
26.98K
Nov 18
Form 4
—
0
$40.78
-$206,939.00
26.98K
Oct 23
Form 4
—
0
$42.77
-$246,795.89
26.86K
Aug 7
Form 4
-10.12%
-3.00K
$55.86
-$167,580.00
26.66K
May 12
Form 4
+10.84%
2.9K
—
—
29.66K
May 8
Form 4
+29.70%
6K
—
—
26.2K
May 10
Form 4
-1.14%
-230.00
—
—
20.02K
Oct 31
Form 4
—
0
$34.15
-$523,338.16
20.25K
Oct 26
Form 4
+43.28%
6K
—
—
19.86K
May 11
Form 4
+86.13%
6K
—
—
12.97K
May 12
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Jun 30
No matching records found

AVANIR PHARMACEUTICALS, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+37.19%
21.7K
—
—
80.05K
Feb 12
Form 4
∞
58.35K
—
—
58.35K
Mar 11
Form 3
—
0
—
—
0
No matching records found

ONYX PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.10K
$125.00
-$262,500.00
0
Oct 1
Form 4
-41.67%
-1.50K
$131.26
-$196,890.00
2.1K
Scheduled
Jul 30
Form 4
-58.14%
-5.00K
$132.63
-$663,150.00
3.6K
Scheduled
Jul 1
Form 4
-10.42%
-1.00K
$88.25
-$88,250.00
8.6K
Scheduled
Jun 19
Form 4
+28.00%
2.1K
—
—
9.6K
Mar 28
Form 4
-34.58%
-3.96K
$75.00
-$297,300.00
7.5K
Nov 28
Form 4
+15.05%
1.5K
—
—
11.46K
Jul 25
Form 4
+43.08%
3K
—
—
9.96K
Mar 30
Form 4
+75.68%
3K
—
—
6.96K
Mar 31
Form 4
+33.74%
1K
—
—
3.96K
May 26
Form 4
+207.47%
2K
—
—
2.96K
Mar 31
Form 4
∞
964
—
—
964
Mar 31
Form 4
—
0
—
—
0
Oct 6
Form 4
—
0
$26.21
-$174,932.00
0
May 28
Form 4
—
0
—
—
0
Oct 5
Form 4
—
0
—
—
0
Oct 5
Form 4
—
0
—
—
0
Oct 5
Form 3
—
0
—
—
0
No matching records found